normal phenotype
|
• viable and fertile with no signs of neuropathy or motor weakness
|
Analysis Tools|
Allele Symbol Allele Name Allele ID |
Slc12a6tm1Garo targeted mutation 1, Guy A Rouleau MGI:5318538 |
||||||||||||
| Summary |
2 genotypes
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• viable and fertile with no signs of neuropathy or motor weakness
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• unable to successfully breed
|
|
• progressive peripheral neuropathy starting at 3-4 weeks of age
|
|
• at 2 months of age
|
|
• hypoplastic with a small but significant decrease in length
|
|
• axon swelling in sciatic nerves
|
|
• axon degeneration, hypomyelination and axon swelling in sciatic nerves
|
|
• in sciatic nerves
|
|
• hypomyelination in sciatic nerves
|
|
• by 3-4 weeks of age
|
|
• severe locomotor deficiencies
• deficiencies become more severe after 8 months of age
|
|
• significant increase in the total distance traveled and the number of movement bouts at 5 months of age
|
|
• significantly less sensitive in a formalin test of spontaneous chemical/inflammatory pain
|
|
• at 2 months of age
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
| agenesis of the corpus callosum with peripheral neuropathy | DOID:0090003 |
OMIM:218000 |
J:183239 | |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
|
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 09/30/2025 MGI 6.24 |
|
|
|
||


